FDA Expands Finerenone to Type 1 Diabetes CKD
FDA approved finerenone (Kerendia) to reduce urine albumin-to-creatinine ratio in adults with chronic kidney disease associated with type 1 diabetes. Bayer describes this as the first FDA-approved treatment option in more than 30 years…
